Гигантская ангиомиолипома почки на примере клинических наблюдений

Приведены два клинических наблюдения пациентов с гигантскими ангиомиолипомами (АМЛ) почек, одна из которых имела осложненное течение вследствие внутриопухолевого кровоизлияния. Описаны ключевые диагностические критерии при применении компьютерной томографии (КТ), а также отличительные особенности других новообразований, с которыми необходимо проводить дифференциальную диагностику. Схожая клиническая картина и морфологические характеристики различных новообразований почек могут вызвать определенные диагностические трудности, однако тщательно собранный анамнез и отличительные критерии позволяют идентифицировать АМЛ. КТ брюшной полости с контрастным усилением вследствие высокой чувствительности и специфичности является эффективным методом визуализации в выявлении и дифференциальной диагностике гигантских АМЛ почек.

1. Wang ZJ, Westphalen AC, Zagoria RJ. CT and MRI of small renal masses. The Br J Radiol. 2018; 91(1087): 20180131. https://doi.org/10.1259/bjr.20180131.

2. Yang G, Gong A, Nie P, et al. Contrast-enhanced CT texture analysis for distinguishing fat-poor renal angiomyolipoma from chromophobe renal cell carcinoma. Mol Imaging. 2019; 18. https://doi.org/10.1177/1536012119883161.

3. Liu Y, Qu F, Cheng R, Ye Z. CT-imaging features of renal epithelioid angiomyolipoma. World J Surg Oncol. 2015; 13: 280. https://doi.org/10.1186/s12957-015-0700-9.

4. Takashi H, Shin E. Renal angiomyolipoma with tuberous sclerosis complex: how it differs from sporadic angiomyolipoma in both management and care. Asian J Surg. 2020; 43(10): 967–72. https://doi.org/10.1016/j.asjsur.2019.12.008.

5. Kaur G, Thajudeen B. Asymptomatic bilateral giant angiomyolipoma. Saudi J Kidney Dis Transpl. 2017; 28: 675–7. https://doi.org/10.4103/1319-2442.206449.

6. Chen P, Jin L, Yang Y, et al. Giant renal angiomyolipoma: a case report. Mol Clin Oncol. 2017; 7(2): 298–300. https://doi.org/10.3892/mco.2017.1305.

7. Taneja R, Singh D. Giant renal angiomyolipoma: unusual cause of huge abdominal mass. J Clin Imaging Sci. 2013; 3(1): 56. https://doi.org/10.4103/2156-7514.122326.

8. Seyam RM, Bissada NK, Kattan SA, et al. Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology. 2018: 72(5): 1077–82. https://doi.org/10.1016/j.urology.2008.07.049.

9. Sahar EA, Faten F, Mouna S, et al. Tuberous sclerosis complex (Bourneville–Pringle disease) in a 25-year-old female with bilateral renal angiomyolipoma and secondary hypertension. Saudi J Kidney Dis Transpl. 2017; 3: 633–8. https://doi.org/10.4103/1319-2442.206461.

10. Khaddour K, Shayuk M. Lymphangioleiomyomatosis. Treasure Island (FL): StatPearls Publishing; 2021.

11. Sclafani A, VanderLaan P. Lymphangioleiomyomatosis. N Engl J Med. 2018; 378(23): 2224. https://doi.org/10.1056/NEJMicm1712581.

12. Jinzaki M, Silverman SG, Akita H, et al. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging. 2014; 39: 588–604. https://doi.org/10.1007/s00261-014-0083-3.

13. Samuels JA. Treatment of renal angiomyolipoma and other hamartomas in patients with tuberous sclerosis complex. Clin J Am Soc Nephrol. 2017; 12(7): 1196–202. https://doi.org/10.2215/CJN.08150816.

14. Portocarrero L, Quental K, Samorano L, et al. Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol. 2018; 93(3): 323–31. https://doi.org/10.1590/abd1806-4841.20186972.

15. Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 2010; 41(5): 199–208. https://doi.org/10.1055/s-0030-1269906.

16. Froemming A, Boland J, Cheville J, et al. Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. Am J Roentgenol. 2013; 200(2): 178–86. https://doi.org/10.2214/AJR.12.8776.

17. Park JH, Lee C, Suh JH, et al. Renal epithelioid angiomyolipoma: histopathologic review, immunohistochemical evaluation and prognostic significance. Pathol Int. 2016; 66(10): 571–7. https://doi.org/10.1111/pin.12458.

18. de Miranda CLVM, de Sousa CS, Bastos BB, et al. Giant renal angiomyolipomas in a patient with tuberous sclerosis. Radiol Bras. 2018; 51(1): 64–5. https://doi.org/10.1590/0100-3984.2016.0082.

19. Sanchez A, Feldman AS, Hakimi AA. Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation. J Clin Oncol. 2018; 36(36): 3591–600. https://doi.org/10.1200/JCO.2018.79.2341.

20. Матвеев В.Б., Волкова М.И., Гурарий Л.Л. и др. Гигантские ангиомиолипомы почек как проявление болезни Бурневилля–Прингла. Онкоурология. 2011; 3: 132–5. https://doi.org/10.17650/1726-9776-2011-7-3-132-135.

21. Galatola R, Stanzione A, Sirignano C, et al. Giant epithelioid angiomyolipoma: an imaging-related differential diagnosis among fat-containing renal masses. Clin Genitourin Cancer. 2020; 18(1): 5–9. https://doi.org/10.1016/j.clgc.2019.10.028.

22. Tahri R, Gamra L, Otmany A. Liposarcoma in the renal compartment: about two cases and literature review. Pan Afr Med J. 2018; 29: 167 (in French). https://doi.org/10.11604/pamj.2018.29.167.1850.

23. Aldrink JH, Heaton TE, Dasgupta R, et al. American Pediatric Surgical Association Cancer Committee (2019). Update on Wilms tumor. J Pediatr Surg. 2019; 54(3): 390–7. https://doi.org/10.1016/j.jpedsurg.2018.09.005.

24. Flum AS, Hamoui N, Said MA, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2016; 195(4): 834–46. https://doi.org/10.1016/j.juro.2015.07.126.

25. Amin S, Kingswood JC, Bolton PF, et al. The UK guidelines for management and surveillance of tuberous sclerosis complex. Int J Med. 2019; 112(3): 171–82. https://doi.org/10.1093/qjmed/hcy215.

26. Kara O, Akca O, Zargar H, et al. Robotic partial nephrectomy in the treatment of renal angiomyolipoma. J Endourol. 2016; 30(3): 275–9. https://doi.org/10.1089/end.2015.0624.

27. Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013; 381(9869): 817–24. https://doi.org/10.1016/S0140-6736(12)61767-X.